Jennifer O’Farrell, Attorney, and member of the renowned Biotechnology and Life Sciences Group at Boult Wade Tennant, provides commentary in recently published Bio-Science Law Review Issue 4 Volume 14.
In this prestigious journal for law professionals working in the field of bio-science, Jennifer provides a case comment on the Court of Justice of the European Union’s (CJEU) ruling on the requirements for protecting carrier proteins using Supplementary Protection Certificates. Specifically she explores a recent judgement and the CJEU’s interpretation of Articles 3(a) and 3(b).
This invited paper was based on an earlier Bulletin, co-authored with Boult Wade Tennant Patent Assistant Dr David Wortley, entitled ‘CJEU confirms that mere carrier proteins are not active ingredients in the context of SPCs’. Click here to read this in full.
For further information, please contact your usual Boult Wade Tennant advisor or email@example.com.